| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8215805 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 7 Pages |
Abstract
Several low- and high-risk factors that may assist with tailoring future clinical trial QA were identified. Because the real-time resubmission rate was largely independent of the credentialing exercise, some form of RTR QA is recommended. The greatest benefit from QA was derived early in trial activation and clinician experience.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yuvnik MBBS, Andrew FRANZCR, Andrea BAppSc, Maria MBChB, FRANZCR, Mark FRANZCR, Colin FRANZCR, Kirsty FRANZCR, Annette PhD, Carol BA, Jarad FRANZCR,